臺北醫學大學新藥開發研究中心

2025

Development of BACE2-IN-1/tranylcypromine-based compounds to induce steroidogenesis-dependent neuroprotection

Banerjee, S., Hsu, Y. T., Nguyen, D. H., Yeh, S. H., Liou, K. C., Liu, J. J., Liou, J. P. & Chuang, J. Y., 2月 2025, 於: Biomedicine and Pharmacotherapy. 183, 117851.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase

Chu, J. C., Tsai, K. C., Wang, T. Y., Chen, T. Y., Tsai, J. Y., Lee, T., Lin, M. H., Hsieh, Y. S. Y., Wu, C. C. & Huang, W. J., 2月 5 2025, 於: European Journal of Medicinal Chemistry. 283, p. 117169 117169.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Genetic variants of IGF2BP2 as potential predictors for perineural invasion of prostate cancer in a Taiwanese population

Weng, W. C., Lin, Y. W., Lai, C. H., Lin, C. Y., Wen, Y. C., Chang, L. C., Yang, S. F. & Chien, M. H., 2025, 於: International Journal of Medical Sciences. 22, 6, p. 1269-1277 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Hypoxia enhances IL-8 signaling through inhibiting miR-128-3p expression in glioblastomas

Ho, K. H., Hsu, S. Y., Chen, P. H., Cheng, C. H., Liu, A. J., Chien, M. H. & Chen, K. C., 2月 2025, 於: Biochimica et Biophysica Acta - Molecular Cell Research. 1872, 2, 119885.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies

Chen, I. C., Lin, H. Y., Liu, Z. Y., Cheng, W. J., Yeh, T. Y., Yang, W. B., Tran, H. Y., Lai, M. J., Wang, C. H., Kao, T. Y., Hung, C. Y., Huang, Y. L., Liou, K. C., Hsieh, C. M., Hsu, T. I. & Liou, J. P., 2025, 於: Journal of Medicinal Chemistry. 68, 3, p. 2779-2803 25 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8⁺ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1

Yang, W. H., Huang, B. Y., Rao, H. Y., Ye, P., Chen, B., Wang, H. C., Chung, C. H., Wu, H. H., Yen, H. R., Wang, S. C., Cha, J. H., Yan, X., Yang, M. H. & Hung, M. C., 2025, (接受/付印) 於: Advanced Science.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

The off‑target effect of loratadine triggers autophagy‑mediated apoptosis in lung adenocarcinoma cells by deactivating JNK, p38, and STAT3 signaling through both PP2A‑dependent and independent pathways

Chien, M. H., Hung, W. Y., Lai, T. C., Tsai, C. H., Lee, K. L., Hsieh, F. K., Lee, W. J. & Chang, J. H., 4月 2025, 於: International Journal of Molecular Medicine. 55, 4

研究成果: 雜誌貢獻 › 文章 › 同行評審

Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids

Li, C. Y., Fan, L. Y., Lin, C. H., Hu, C. J. & Chiu, M. J., 2月 25 2025, 於: ACS Omega. 10, 7, p. 7256-7263 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2024

An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors

Lin, T. E., Yen, D., HuangFu, W. C., Wu, Y. W., Hsu, J. Y., Yen, S. C., Sung, T. Y., Hsieh, J. H., Pan, S. L., Yang, C. R., Huang, W. J. & Hsu, K. C., 6月 2024, 於: Protein Science. 33, 6, e5007.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress

Wu, L. H., Cheng, Y. W., Lin, F. L., Hsu, K. C., Wang, M. H., Yen, J. L., Wang, T. J., Lin, T. E., Liu, Y. C., Huang, W. J. & Hsiao, G., 5月 2024, 於: Biomedicine and Pharmacotherapy. 174, 116538.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells

Chan, T. S., Cheng, L. H., Hsu, C. C., Yang, P. M., Liao, T. Y., Hsieh, H. Y., Lin, P. C., HuangFu, W. C., Chuu, C. P. & Tsai, K. K., 2024, (接受/付印) 於: Molecular Oncology. 18, 3, p. 562-579 18 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Associations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer

Tung, M. C., Lin, C. Y., Wen, Y. C., Chang, L. C., Yang, S. F. & Chien, M. H., 12月 2024, 於: Journal of Cellular and Molecular Medicine. 28, 23, e70264.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

A tumor on a chip for studying immune-cell infiltration into tumor under chemo/immunotherapy treatments

Chen, Y. C., Lee, K. Y., Liao, H. J., Sun, W. L., Huang, W. C., Wang, Y. S., Chang, W. C. & Liu, C. H., 5月 1 2024, 於: Sensors and Actuators B: Chemical. 406, 135409.

研究成果: 雜誌貢獻 › 文章 › 同行評審

6 引文斯高帕斯（Scopus）

Bioactive matrix scaffold of oxidized sacchachitin via green catalyst of siliacat tempo for enhancing bone regeneration

Sheu, M. T., Lin, S. Y., Cheng, W. J., Lin, H. L., Hsieh, C. M., Ho, H. O., Chen, L. C. & Wu, M. H., 12月 2024, 於: Carbohydrate Polymer Technologies and Applications. 8, 100576.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Celecoxib attenuates interleukin 33-induced expression of vascular cell adhesion molecule-1 in human ovarian endometriotic stromal cells

Lin, T. C., Wang, K. H., Chuang, K. H., Kao, A. P. & Kuo, T. C., 3月 2024, 於: Taiwanese Journal of Obstetrics and Gynecology. 63, 2, p. 178-185 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Characterization of primary Sjögren's syndrome in the Taiwan Han population through a genome-wide association study and polygenic risk score analysis

Liu, T. Y., Lin, M. R., Lu, H. F., Chen, Y. C., Lin, H. J., Chou, W. H., Wei, C. Y., Palupi, P. D., Liao, C. C., Chang, Y. T., Chang, W. C. & Tsai, F. J., 12月 2024, 於: Clinical Immunology. 269, 110381.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models

Chang, T. Y., Yan, Y., Yu, Z. Y., Rathore, M., Lee, N. Z., Tseng, H. J., Cheng, L. H., Huang, W. J., Zhang, W., Chan, E. R., Qing, Y., Kang, M. L., Wang, R., Tsai, K. K., Pink, J. J., Harte, W. E., Gerson, S. L. & Lee, S. B., 12月 2 2024, 於: Journal of Clinical Investigation. 134, 23, e165448.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Corrigendum to "Chemical constituents from a marine medicinal brown alga-derived Xylaria acuta SC1019" [J Food Drug Anal 32 (2) (2024)

Hsi, H. Y., Wang, S. W., Hsiao, G., Chang, L. K., Cheng, Y. C., Huang, S. J., Lu, Y. S. & Lee, T. H., 9月 13 2024, 於: Journal of Food and Drug Analysis. 32, 3, p. 384 1 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity

Liu, C. C., Yang, W. B., Chien, C. H., Wu, C. L., Chuang, J. Y., Chen, P. Y., Chu, J. M., Cheng, S. M., Qiu, L. Y., Chang, Y. C., Hwang, D. Y., Huang, C. Y., Lee, J. S. & Chang, K. Y., 6月 2024, 於: Cell Death and Disease. 15, 6, 434.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agents

Sethy, B., Yu, Z. Y., Narwanti, I., Upadhyay, R., Lai, M. J., Lee, S. B. & Liou, J. P., 12月 2024, 於: Bioorganic Chemistry. 153, 107771.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Dietary contributions in the genetic variation of liver fibrosis: a genome-wide association study of fibrosis-4 index in the liver fibrosis development

Palupi, P. D., Wei, C. Y., Chou, W. H., Lin, M. R., Wan, Y. J. Y. & Chang, W. C., 12月 2024, 於: Cell and Bioscience. 14, 1, 141.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation

Tu, H. J., Chao, M. W., Lee, C. C., Peng, C. S., Wu, Y. W., Lin, T. E., Chang, Y. W., Yen, S. C., Hsu, K. C., Pan, S. L. & HuangFu, W. C., 2024, 於: Journal of Enzyme Inhibition and Medicinal Chemistry. 39, 1, 2418470.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia

Huang, Y. H., Lin, S. Y., Ou, L. C., Huang, W. C., Chao, P. K., Chang, Y. C., Chang, H. F., Lee, P. T., Yeh, T. K., Kuo, Y. H., Tien, Y. W., Xi, J. H., Tao, P. L., Chen, P. Y., Chuang, J. Y., Shih, C., Chen, C. T., Tung, C. W., Loh, H. H. & Ueng, S. H. 及其他1, Yeh, S. H., 2024, (接受/付印) 於: Cell Chemical Biology. 31, 11, p. 1885-1898.e10

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics

Chen, J. H., Tu, H. J., Lin, T. E., Peng, Z. X., Wu, Y. W., Yen, S. C., Sung, T. Y., Hsieh, J. H., Lee, H. Y., Pan, S. L., HuangFu, W. C. & Hsu, K. C., 12月 2024, 於: Biomedicine and Pharmacotherapy. 181, 117688.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection

Tai, L. T., Yeh, C. Y., Chang, Y. J., Liu, J. F., Hsu, K. C., Cheng, J. C. & Lu, C. H., 6月 2024, 於: International journal of molecular sciences. 25, 11, 6105.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma

Shih, W. H., Huang, H. L., HuangFu, W. C., Lin, T. E., Sung, T. Y., Li, M. C., Huang, G. L., Chang, Y. W., Yen, S. C., Hsieh, H. P., Hsu, K. C. & Pan, S. L., 12月 2024, 於: International Journal of Biological Macromolecules. 283, 137296.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Disulfiram inhibits coronaviral main protease by conjugating to its substrate entry site

Kuan, Y., Chu, H. F., Hsu, P. H., Hsu, K. C., Lin, T. H., Huang, C. H. & Chen, W. Y., 9月 2024, 於: International Journal of Biological Macromolecules. 276, 133955.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

Sharma, R., Chiang, Y. H., Chen, H. C., Lin, H. Y., Yang, W. B., Nepali, K., Lai, M. J., Chen, K. Y., Liou, J. P. & Hsu, T. I., 4月 1 2024, 於: Cancer Letters. 586, 216666.

研究成果: 雜誌貢獻 › 文章 › 同行評審

4 引文斯高帕斯（Scopus）

Dynamics of T-cell receptor repertoire in patients with ankylosing spondylitis after biologic therapy

Liu, W. C., Chang, C. M., Zhang, Y., Liao, H. T. & Chang, W. C., 1月 25 2024, 於: International Immunopharmacology. 127, 111342.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Effect of Sulfotyrosine and Negatively Charged Amino Acid of Leech-Derived Peptides on Binding and Inhibitory Activity Against Thrombin

Chen, T.-Y., Shyur, E., Ma, T.-H., Wijeyewickrema, L., Lin, S.-W., Kao, M.-R., Liang, P.-H., Shie, J.-J., Chuang, E.-Y., Liou, J.-P. & Hsieh, Y. S., 2月 1 2024, 於: ChemBioChem. 25, 3, p. e202300744 e202300744.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways

Lee, H. Y., Hsu, M. J., Chang, H. H., Chang, W. C., Huang, W. C. & Cho, E. C., 7月 15 2024, 於: Bioorganic and Medicinal Chemistry. 109, 117792.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development

Lin, H. Y., Tsai, T. N., Hsu, K. C., Hsu, Y. M., Chiang, L. C., El-Shazly, M., Chang, K. M., Lin, Y. H., Tu, S. Y., Lin, T. E., Du, Y. C., Liu, Y. C. & Lu, M. C., 7月 2024, 於: Marine Drugs. 22, 7, 323.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

GRK6 palmitoylation dictates triple-negative breast cancer metastasis via recruiting the β-Arrestin 2/MAPKs/NF-κB signaling axis

Wang, W. K., Lin, H. Y., Lin, C. H., Lee, H. H., Chen, Y. L., Lin, Y. H. K., Chiu, H. W., Sheen-Chen, S. M. & Lin, Y. F., 12月 2024, 於: Breast Cancer Research. 26, 1, 193.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids

Tang, D. W., Chen, I. C., Chou, P. Y., Lai, M. J., Liu, Z. Y., Tsai, K. K., Cheng, L. H., Zhao, J. X., Cho, E. C., Chang, H. H., Lin, T. E., Hsu, K. C., Chen, M. C. & Liou, J. P., 11月 15 2024, 於: European Journal of Medicinal Chemistry. 278, 116801.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor

Peng, C. H., Hwang, T. L., Hung, S. C., Tu, H. J., Tseng, Y. T., Lin, T. E., Lee, C. C., Tseng, Y. C., Ko, C. Y., Yen, S. C., Hsu, K. C., Pan, S. L. & HuangFu, W. C., 12月 2024, 於: International Journal of Biological Macromolecules. 282, 136860.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule

Wu, Y. W., HuangFu, W. C., Lin, T. E., Peng, C. H., Tu, H. J., Sung, T. Y., Sung, T. Y., Yen, S. C., Pan, S. L. & Hsu, K. C., 2月 2024, 於: International Journal of Biological Macromolecules. 259, 129074.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

IL-33/ST2 axis mediates diesel exhaust particles-induced mast cell activation

Cheng, W. H., Zhuang, T. L., Lee, M. J., Chou, C. L., Chen, B. C., Kuo, H. P. & Weng, C. M., 12月 2024, 於: Molecular Medicine. 30, 1, 262.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer

Huang, C. C., Hsu, C. M., Chao, M. W., Hsu, K. C., Lin, T. E., Yen, S. C., Tu, H. J. & Pan, S. L., 6月 2024, 於: Protein Science. 33, 6, e5004.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression

Panda, S. S., Lee, C. C., Geevimaan, K., Chen, K. C., Yang, S. H., Shen, C. N., HuangFu, W. C. & Wu, H. C., 12月 2024, 於: Journal of Biomedical Science. 31, 1, 72.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation

Thakur, A., Chu, Y. H., Rao, N. V., Mathew, J., Grewal, A. S., Prabakaran, P., Guru, S., Liou, J. P., Pan, C. H. & Nepali, K., 7月 5 2024, 於: European Journal of Medicinal Chemistry. 273, 116507.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes

Do, A. D., Wu, K. S., Chu, S. S., Giang, L. H., Lin, Y. L., Chang, C. C., Wong, T. T., Hsieh, C. L. & Sung, S. Y., 12月 2024, 於: Journal of Experimental and Clinical Cancer Research. 43, 1, 130.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Maintaining KEAP1 levels in retinal pigment epithelial cells preserves their viability during prolonged exposure to artificial blue light

Li, C. H., Yang, T. M., Fitriana, I., Fang, T. C., Wu, L. H., Hsiao, G. & Cheng, Y. W., 11月 2024, 於: Journal of Photochemistry and Photobiology B: Biology. 260, 113037.

研究成果: 雜誌貢獻 › 文章 › 同行評審

MPT0E028, a novel pan-HDAC inhibitor, prevents pulmonary fibrosis through inhibition of TGF-β-induced CTGF expression in human lung fibroblasts: Involvement of MKP-1 activation

Liu, C. H., Lee, H. S., Liou, J. P., Hua, H. S., Cheng, W. H., Yuliani, F. S., Chen, B. C. & Lin, C. H., 8月 15 2024, 於: European Journal of Pharmacology. 977, 176711.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Sethy, B., Upadhyay, R., Narwanti, I., Yu, Z. Y., Lee, S. B. & Liou, J. P., 2024, (接受/付印) 於: Apoptosis. 29, 11-12, p. 2047-2073 27 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations

Yugatama, A., Huang, Y. L., Hsu, M. J., Lin, J. P., Chao, F. C., Lam, J. K. W. & Hsieh, C. M., 2024, 於: International Journal of Nanomedicine. 19, p. 3753-3772 20 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population

Chou, W. H., Chen, L. C., Wong, H. S. C., Chao, C. H., Chu, H. W. & Chang, W. C., 12月 2024, 於: Biomarker Research. 12, 1, 46.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Rationally designed febuxostat-based hydroxamic acid and its pH-Responsive nanoformulation elicits anti-tumor activity

Ritika, Liao, Z. Y., Chen, P. Y., Rao, N. V., Mathew, J., Sharma, R., Grewal, A. S., Singh, G., Mehan, S., Liou, J. P., Pan, C. H. & Nepali, K., 2024, 於: European Journal of Medicinal Chemistry. 279, 116866.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids

Chou, P. Y., Lai, M. J., Tsai, K. K., Cheng, L. H., Wu, Y. W., Chen, M. C., Pan, S. L., Ho, H. O., Nepali, K. & Liou, J. P., 2024, (接受/付印) 於: Journal of Medicinal Chemistry. 67, 19, p. 17207-17225 19 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases

Hsu, K. C., Huang, Y. Y., Chu, J. C., Huang, Y. W., Hu, J. L., Lin, T. E., Yen, S. C., Weng, J. R. & Huang, W. J., 2024, 於: Journal of Enzyme Inhibition and Medicinal Chemistry. 39, 1, 2406025.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis

Huynh, D. T. N., Nguyen, H. T. & Hsieh, C. M., 2024, (接受/付印) 於: Molecular Diversity.

研究成果: 雜誌貢獻 › 文章 › 同行評審

臺北醫學大學新藥開發研究中心

研究成果

搜尋結果